JPM26: Intellia Therapeutics hopeful on CRISPR safety despite patient death
Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare Conference 2026.
JPM26: Sanofi’s COAST 1 clinical trials exhibit positive results, with researchers optimistic for COAST 2 results for amlitelimab
Akeso’s PD-1/CTLA-4 bispecific trumps chemo in frontline gastric cancer
ImmunityBio’s Anktiva shows success as combo treatment in NSCLC
JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data
New study finds stroke associated with poor glycemic control in diabetics
Analysis
View More
Themes
View MoreRevealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
91% of clinical research associates concerned with burnout and turnover, third-party data query resolution can cost sponsors millions.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment